Clinical Trial

Blocking Blue Light in Pregnancy, Effects on Melatonin Profile and Sleep

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Sleep disturbances are common in pregnancy, and the incidence increases during the third trimester. Light and specially the blue wavelengths of light, is affecting sleep and the circadian rhythm. The main aim of this randomized controlled study is to investigate the effect of Blue-blocking glasses (BB-glasses) used in the evening and night on sleep and mood in pregnant women in the third trimester. The outcome measures assess sleep variables, alertness, melatonin level, sleepiness (subjectively), mood and symptoms of anxiety and depression. In addition we want to measure the pregnancy related sleep problems, alcohol intake, physical activity and perceives stress in the study population, and the association with daily/nightly light exposure.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2017-04-13; most recent amendment 2024-12-16.
Status change: Recruiting → Active, Not Recruiting 2019-05-07
Status change: Not Yet Recruiting → Recruiting 2017-10-31
Trial Details
NCT Number NCT03114072
Lead Sponsor University of Bergen
Collaborators: The Norwegian Competence Center for Sleep Disorders (SOVno), Western Norway University of Applied Sciences
Conditions Sleep Disturbance
Enrollment 60 participants
Start Date 2017-06-06
Primary Completion 2019-04-09 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-12-18